Halozyme Therapeutics, Inc. (NASDAQ:HALO – Get Free Report) Director Matthew L. Posard sold 10,000 shares of the firm’s stock in a transaction dated Tuesday, June 11th. The stock was sold at an average price of $50.01, for a total value of $500,100.00. Following the completion of the transaction, the director now directly owns 109,755 shares […]
Halozyme Therapeutics, Inc. (NASDAQ:HALO – Get Free Report) Director Matthew L. Posard sold 10,000 shares of the firm’s stock in a transaction dated Tuesday, June 11th. The stock was sold at an average price of $50.01, for a total value of $500,100.00. Following the completion of the transaction, the director now directly owns 109,755 shares […]
Scout Investments Inc. decreased its position in Halozyme Therapeutics, Inc. (NASDAQ:HALO – Free Report) by 1.5% in the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 261,483 shares of the biopharmaceutical company’s stock after selling 4,095 shares during the period. Scout Investments Inc. owned about 0.20% of Halozyme […]
Epoch Investment Partners Inc. raised its position in Halozyme Therapeutics, Inc. (NASDAQ:HALO – Free Report) by 250.5% during the 4th quarter, Holdings Channel.com reports. The institutional investor owned 1,163,033 shares of the biopharmaceutical company’s stock after buying an additional 831,199 shares during the quarter. Epoch Investment Partners Inc.’s holdings in Halozyme Therapeutics were worth $42,986,000 […]
Evoke Wealth LLC purchased a new position in shares of Halozyme Therapeutics, Inc. (NASDAQ:HALO – Free Report) during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 36,657 shares of the biopharmaceutical company’s stock, valued at approximately $1,355,000. A number of other […]
TD Asset Management Inc Increases Stake in Halozyme Therapeutics, Inc. (NASDAQ:HALO) dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.
TD Asset Management Inc Increases Holdings in Halozyme Therapeutics, Inc. (NASDAQ:HALO) wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.
Bernzott Capital Advisors trimmed its position in Halozyme Therapeutics, Inc. (NASDAQ:HALO – Free Report) by 27.3% during the fourth quarter, Holdings Channel reports. The institutional investor owned 124,979 shares of the biopharmaceutical company’s stock after selling 46,829 shares during the quarter. Bernzott Capital Advisors’ holdings in Halozyme Therapeutics were worth $4,619,000 at the end of […]
HC Wainwright reiterated their buy rating on shares of Halozyme Therapeutics (NASDAQ:HALO – Free Report) in a report issued on Wednesday, Benzinga reports. The firm currently has a $50.00 price objective on the biopharmaceutical company’s stock. Other equities research analysts also recently issued research reports about the stock. TD Cowen began coverage on shares of […]
HC Wainwright restated their buy rating on shares of Halozyme Therapeutics (NASDAQ:HALO – Free Report) in a research note released on Wednesday morning, Benzinga reports. They currently have a $50.00 target price on the biopharmaceutical company’s stock. Other analysts have also issued reports about the stock. JMP Securities cut their target price on shares of […]